Hyrra Features the Latest and Most Talked-About Topstories News and Headlines from Around the World.
⎯ 《 Hyrra • Com 》

List of All Articles with Tag '3400398z us'

Philips Sleep Apnea Machine Safety Fears Grow; Shares Slump
Philips Sleep Apnea Machine Safety Fears Grow; Shares Slump
Royal Philips NV slumped after the Food and Drug Administration warned about a new safety issue involving the
2023-11-29 17:16
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:55
FDA Weighing What to Do About $900,000 Drug That May Not Work
FDA Weighing What to Do About $900,000 Drug That May Not Work
The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US
2023-11-16 18:57
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left —
2023-11-10 18:56
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:20
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:15
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal 
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal 
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:57
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:20
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:23